Abstract
Obstructive sleep apnea (OSA) is highly prevalent and associated with adverse cardiovascular and metabolic outcomes. CPAP therapy is effective but long-term adherence is poor. While standard coaching improves outcomes, sustained adherence remains a challenge. Remote patient monitoring (RPM) platforms may provide an innovative method to improve adherence through continuous feedback, patient engagement, and structured escalation pathways. This randomized controlled trial will evaluate whether adding the MonitAir RPM platform to the standard-of-care program provided by BetterNight improves CPAP adherence and patient satisfaction over 90 days.
Aim
To evaluate whether adding the MonitAir remote patient monitoring (RPM) platform to BetterNight’s standard-of-care CPAP program improves adherence, patient satisfaction, and time to CMS-defined adherence in adults with obstructive sleep apnea.
Intended Impact of the Study
This study will provide some of the first randomized evidence evaluating a remote patient monitoring platform for CPAP adherence in real-world clinical practice. Findings will inform clinicians, digital health developers, and payers on how digital RPM can improve patient engagement, adherence, and outcomes in sleep medicine. The results may guide implementation strategies for RPM in other chronic disease areas.
Project Lead
Project Collaborators
Dominic Munafo
Bretton Lane
William Hevener
Simba Nyanhongo
Edward Mezerhane
Aron Bobrowski
Contact Project Author
Keywords
CPAP adherence; Remote patient monitoring; obstructive sleep apnea; patient engagement; randomized trial; sleep medicine; telehealth
Research Area(s)
Data visualization; Design and conduct of studies; Digital tools; Recruitment and retention; Reporting standards
Other Areas: Remote patient monitoring, CPAP adherence, digital health interventions, telehealth, sleep medicine, patient engagement, implementation science.
Study Design(s)
Other Designs: Randomized, controlled, parallel-group trial (2 arms, 1:1 allocation, 200 participants total, 90-day follow-up).
Data Collection Method(s)
Participant(s)
Other Participants: Adults (≥18 years) with obstructive sleep apnea (AHI ≥5), initiating CPAP/APAP therapy, owning a smartphone, and able to engage in telemonitoring. Excluded: DOT drivers, central apnea predominance, use of BiPAP/ASV, or unwillingness to participate.
Status
Complete
Stage
Data analysis; Publication (writing, submitting, in review, published); Study is complete and only conducting dissemination activities (e.g., stakeholder engagement, presentations, conferences and seminars, social media campaigns)
Study Funding/Support
Industry-sponsored collaboration between MonitAir LLC and BetterNight, not supported by an external research grant.; Other
Other(s): Industry-sponsored collaboration between MonitAir LLC and BetterNight, without external grant funding.
Dissemination Activity/Activities
Other(s): Preparation of peer-reviewed manuscript; abstract submission to national sleep and cardiology conferences; dissemination through partner clinics and digital health networks.